Publikationen in Zusammenarbeit mit Forschern von National Institute for Health Development (22)

2024

  1. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study

    The Lancet Oncology, Vol. 25, Núm. 3, pp. 293-307

  2. Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study

    The Lancet Oncology

2022

  1. Association of Sentinel Node Biopsy and Pathological Report Completeness with Survival Benefit for Cutaneous Melanoma and Factors Influencing Their Different Uses in European Populations

    Cancers, Vol. 14, Núm. 18

  2. Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries

    The Lancet Child and Adolescent Health, Vol. 6, Núm. 6, pp. 409-431

2021

  1. Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study

    Digestive and Liver Disease, Vol. 53, Núm. 5, pp. 639-645

2020

  1. Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study

    European Journal of Surgical Oncology, Vol. 46, Núm. 6, pp. 1151-1159

  2. Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study

    Breast Cancer Research and Treatment, Vol. 183, Núm. 2, pp. 439-450

2019

  1. Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer

    International Journal of Cancer, Vol. 144, Núm. 9, pp. 2118-2127

2018

  1. Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis?

    European Journal of Cancer, Vol. 93, pp. 127-137

2017

  1. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study

    The Lancet Oncology, Vol. 18, Núm. 8, pp. 1022-1039

  2. Geographical variability in survival of European children with central nervous system tumours

    European Journal of Cancer, Vol. 82, pp. 137-148

  3. Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study

    European Journal of Cancer, Vol. 84, pp. 335-353

2015

  1. Age and case mix-standardised survival for all cancer patients in Europe 1999-2007: Results of EUROCARE-5, a population-based study

    European Journal of Cancer, Vol. 51, Núm. 15, pp. 2120-2129

  2. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study

    European Journal of Cancer, Vol. 51, Núm. 15, pp. 2130-2143

  3. Survival of male genital cancers (prostate, testis and penis) in Europe 1999-2007: Results from the EUROCARE-5 study

    European Journal of Cancer, Vol. 51, Núm. 15, pp. 2206-2216

  4. Survival of women with cancers of breast and genital organs in Europe 1999-2007: Results of the EUROCARE-5 study

    European Journal of Cancer, Vol. 51, Núm. 15, pp. 2191-2205

  5. The EUROCARE-5 study on cancer survival in Europe 1999-2007: Database, quality checks and statistical analysis methods

    European Journal of Cancer, Vol. 51, Núm. 15, pp. 2104-2119

  6. Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5

    European Journal of Cancer, Vol. 51, Núm. 15, pp. 2217-2230

2014

  1. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study

    The Lancet Oncology, Vol. 15, Núm. 1, pp. 23-34

  2. Childhood cancer survival in Europe 1999-2007: Results of EUROCARE-5-a population-based study

    The Lancet Oncology, Vol. 15, Núm. 1, pp. 35-47